EBR Systems, Inc.ASX: EBR

FDA Initiates Inspection of New Manufacturing Facility

· Issued by EBR Systems, Inc. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

EBR Systems, Inc. has announced that the FDA has initiated a pre-approval inspection of its new manufacturing facility in Santa Clara, California, marking a significant regulatory milestone for the company. The company anticipates FDA approval of the facility by the end of the year, which is crucial for its operations in developing wireless cardiac pacing devices.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

EBR SYSTEMS, INC. (ARBN 654 147 127) 4600 Patrick Henry Drive, Santa Clara CA 95054 USA T: +1 408 720 1906 W: https://ebrsystemsinc.com/ ASX ANNOUNCEMENT 15 September 2026 FDA initiates inspection of new manufacturing facility Santa Clara, California; 15 September 2026: EBR...

EBR Systems, Inc. on 6ix

Story so far

Earlier from EBR Systems

Later from EBR Systems

All EBR Systems news releases